Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian Doctors Call For New Rules Against Drug Firm Influence

This article was originally published in PharmAsia News

Executive Summary

Australian physicians are pushing the government to adopt stronger regulations to block the close relationships between drug makers and health professionals. A review of Medicines Australia's code of conduct has attracted thousands of suggestions to tighten ethics rules, complete with fines as much as five times higher than current limits for violations. Some groups want fine limits to be increased to nearly $725,000. Others called for probes of what they call increasing sponsorship of "professional development" activities in clinics they say are disguised promotion of certain drugs. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069873

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel